Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
IDXX
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
-0.73%
$265.46-1.94Delayed quote: Sep 3, 2026, 1:25 PM EDT
Market Cap
$35.52B
52W Range
$197.81 - $495.55
IDXX
IDEXX Laboratories, Inc.
-1.26%
$532.21-6.78Delayed quote: Sep 3, 2026, 1:25 PM EDT
Market Cap
$41.98B
52W Range
$518.55 - $769.98
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 45.17 | 38.17 |
| Forward P/E | 39.80 | 36.49 |
| P/B Ratio | 27.30 | 26.96 |
| P/S Ratio | 7.69 | 9.55 |
| P/FCF Ratio | 68.14 | 34.77 |
| EV/EBITDA | 34.65 | 27.52 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 62.5% |
| Operating Margin | 20.8% | 32.0% |
| Net Margin | 16.8% | 25.0% |
| ROE | 59.7% | 70.7% |
| ROA | 14.5% | 33.1% |
| ROIC | 24.7% | 41.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 1.17 |
| Quick Ratio | 2.99 | 0.87 |
| Debt/Equity | 0.94 | 0.68 |
| Interest Coverage | 1.99 | 35.54 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.